Long term results of surgery for NSCLC and aortic invasion. A multicenter retrospective cohort study

Eur J Surg Oncol. 2022 Apr;48(4):761-767. doi: 10.1016/j.ejso.2021.12.007. Epub 2021 Dec 7.

Abstract

Background: Aortic invasion from non-small cell lung cancers (NSCLC) is a relative contraindication to surgery for oncological and technical reasons. Only a few studies have been published showing good results. Our aim was to evaluate short and long-term results of surgery for T4 NSCLC with aortic resection.

Methods: This is a multicenter retrospective study including 47 patients (33 males and 14 females) who received a major lung resection with aortic surgery in our centers between January 2000 and December 2016.

Results: Adenocarcinoma was diagnosed in 31 patients (66.0%). Induction therapy was used in 14 patients. Pneumonectomy was performed in 34 patients (72.3%). A subadventitial dissection with or without endovascular stent graft was carried out in 40 patients (85.1%), a cardiopulmonary bypass was used in 3 patients and left heart bypass in 4. Intraoperatively, two patients had bleeding (4.3%) and one ventricular fibrillation (2.1%). Twenty-three patients (48.9%) experienced at least one postoperative complication. A radical resection was achieved in 39 patients (83.0%). Thirty-day and 90-day mortality were 2.1% and 4.3%. One-, 3- and 5-year overall survival were 85.1%, 57.4% and 53.2%. Overall and disease-free survivals were significantly influenced by pathological lymph node status and R status that were independent predictive factors for poorer survival at the multivariate analyses.

Conclusions: Aortic resection during surgery for NSCLC is a challenging situation. Nevertheless, oncologic outcomes may be favorable in selected cases justifying a risky procedure that should be performed in experienced hands.

Keywords: Aorta infiltration; Aortic involvement; Locally advanced NSCLC; T4 tumour.

Publication types

  • Multicenter Study

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Disease-Free Survival
  • Female
  • Humans
  • Lung Neoplasms* / pathology
  • Male
  • Neoplasm Staging
  • Pneumonectomy
  • Retrospective Studies